scispace - formally typeset
D

Dan L. Longo

Researcher at Harvard University

Publications -  730
Citations -  59268

Dan L. Longo is an academic researcher from Harvard University. The author has contributed to research in topics: Antigen & Immune system. The author has an hindex of 125, co-authored 697 publications receiving 56085 citations. Previous affiliations of Dan L. Longo include University of Nebraska Omaha & Yale Cancer Center.

Papers
More filters
Journal ArticleDOI

Interleukin-2 and human monocyte activation.

TL;DR: The effects of IL‐2 on human monocytes, the differential expression and modulation of theIL‐2R subunits, and their relationship with the responsiveness of monocyte activation by inhibitory signals are discussed.
Journal ArticleDOI

Transient Improvement in Cognitive Function and Synaptic Plasticity in Rats Following Cancer Chemotherapy

TL;DR: Despite toxicity accompanying chemotherapy, no evidence of impaired cognitive performance emerged after recovery from chemotherapy, and cyclophosphamide- and 5FU-treated rats showed significantly better maze performance compared with controls.
Journal ArticleDOI

Immunomodulators in Clinical Medicine

TL;DR: A major difficulty limiting the use of immunomodulators in clinical medicine has been the complexity of the immunoregulatory network in which modulation of one component usually perturbs another component, and this work aims to address this problem.
Journal ArticleDOI

Changes in expression of signal transduction proteins in T lymphocytes of patients with leprosy.

TL;DR: Major alterations in the expression of signal transduction molecules in T cells of leprosy patients were demonstrated and might improve the understanding of the T-cell dysfunction observed inLeprosy and other infectious diseases and consequently might lead to better immunologic evaluation of patients.
Journal ArticleDOI

Histogenetic correlations between subcategories of small noncleaved cell lymphomas.

TL;DR: The results indicate that the subtle histologic differences that distinguish subcategories of SNCL are significant biologically and reflect distinct molecular mechanisms of lymphomagenesis and confirm the remarkable molecular genetic homogeneity of the sBT group.